Search

Your search keyword '"Saloustros E"' showing total 379 results

Search Constraints

Start Over You searched for: Author "Saloustros E" Remove constraint Author: "Saloustros E"
379 results on '"Saloustros E"'

Search Results

51. Genetic insights into biological mechanisms governing human ovarian ageing

52. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

53. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

54. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

55. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

56. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

57. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

58. Common Susceptibility Loci for Male Breast Cancer

59. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

60. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

61. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

62. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

63. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

64. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

65. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

67. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

68. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

69. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

70. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

71. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

72. Tumor mutational patterns and infiltrating lymphocyte density in young and elderly patients with breast cancer

73. BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

75. Two truncating variants in FANCC and breast cancer risk.

76. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

77. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

78. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

79. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

80. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

81. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

82. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

83. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

84. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

85. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

86. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

87. Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk

88. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

89. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

90. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

92. LBA66_PR Disparities in access to oncology clinical trials in Europe in the period 2009-2019

93. 84P Actual 5-year survival of dose-dense sequential adjuvant chemotherapy in early breast cancer (BC) patients treated in the post-trastuzumab era: A pooled analysis of 3 clinical trials

94. Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

96. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

97. Two truncating variants in FANCC and breast cancer risk

98. Genome-wide association study of germline variants and breast cancer-specific mortality

99. Genome-wide association study of germline variants and breast cancer-specific mortality

100. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Catalog

Books, media, physical & digital resources